Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C14H22N2O3S |
| Molecular Weight | 298.401 |
| Optical Activity | ( + ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)\C=C1/SC(N2CCCCC2)C(=O)N1CC
InChI
InChIKey=UAXYBJSAPFTPNB-KHPPLWFESA-N
InChI=1S/C14H22N2O3S/c1-3-16-11(10-12(17)19-4-2)20-14(13(16)18)15-8-6-5-7-9-15/h10,14H,3-9H2,1-2H3/b11-10-
| Molecular Formula | C14H22N2O3S |
| Molecular Weight | 298.401 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 1 |
| Optical Activity | ( + / - ) |
DescriptionSources: https://www.ndrugs.com/?s=piprozolin
Sources: https://www.ndrugs.com/?s=piprozolin
Piprozolin is a choleretic drug. It was marketed under tradenames Probilin, Secrebil, Prozobil for the treatment of biliary-tract disorders and dyspepsia.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:29:27 GMT 2023
by
admin
on
Sat Dec 16 10:29:27 GMT 2023
|
| Record UNII |
YYW6GMK2YK
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5911905
Created by
admin on Sat Dec 16 10:29:27 GMT 2023 , Edited by admin on Sat Dec 16 10:29:27 GMT 2023
|
PRIMARY | |||
|
YYW6GMK2YK
Created by
admin on Sat Dec 16 10:29:27 GMT 2023 , Edited by admin on Sat Dec 16 10:29:27 GMT 2023
|
PRIMARY | |||
|
95406-07-8
Created by
admin on Sat Dec 16 10:29:27 GMT 2023 , Edited by admin on Sat Dec 16 10:29:27 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
RACEMATE -> ENANTIOMER | |||
|
|
ENANTIOMER -> ENANTIOMER |
|
